IGC Pharma IGC
NYSE IGC
$0.28 +0.01 (+2.28%)
As of: Oct 1, 2026 · 1:46 PM EDT

IGC Pharma (IGC) Liabilities and Shareholders Equity (2011 - 2026)

Updated

IGC Pharma (IGC) recorded Liabilities and Shareholders Equity of $9.19 million in Q4 2026, up 5.0% from $8.75 million a year earlier but down 5.4% from the prior quarter.

Analysis

IGC Pharma (IGC) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Starting with Q4 2011, IGC Pharma's Liabilities and Shareholders Equity history includes 61 quarters.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of -23.8% (FY2021 to FY2026).
  • Across earlier years, Liabilities and Shareholders Equity came in at $8.75 million in FY2025 (-11.7%), $9.9 million in FY2024 (-42.4%), $17.18 million in FY2023 (-36.0%) and $26.83 million in FY2022 (-25.2%).
  • Quarterly Liabilities and Shareholders Equity has ranged from $7.94 million in Q1 2026 to $34.44 million in Q1 2022 over the past five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in two of the last eight quarters, with an average decline of 15.0%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 29.5% in Q3 2022, against a decline of 43.9% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $9.71 million (Q3 2026), $9.74 million (Q2 2026) and $7.94 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 IGC Pharma 26.67 Mn 23.92 Mn 55,000.00 9.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 9.19 Mn
Dec 31, 2025 9.71 Mn
Sep 30, 2025 9.74 Mn
Jun 30, 2025 7.94 Mn
Mar 31, 2025 8.75 Mn
Dec 31, 2024 9.08 Mn
Sep 30, 2024 10.37 Mn
Jun 30, 2024 10.59 Mn
Mar 31, 2024 9.90 Mn
Dec 31, 2023 11.26 Mn
Sep 30, 2023 16.51 Mn
Jun 30, 2023 15.67 Mn
Mar 31, 2023 17.18 Mn
Dec 31, 2022 20.07 Mn
Sep 30, 2022 21.96 Mn
Jun 30, 2022 24.17 Mn
Mar 31, 2022 26.83 Mn
Dec 31, 2021 31.29 Mn
Sep 30, 2021 33.84 Mn
Jun 30, 2021 34.44 Mn
API Access

IGC Pharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IGC&period=max&api_key=YOUR_API_KEY